|This article relies on references to primary sources. (December 2011)|
|Jmol-3D images||Image 1|
|Molar mass||368.38 g mol−1|
|Appearance||Bright yellow-orange powder|
183 °C, 456 K, 361 °F
| (what is: / ?)
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
Curcumin (pronounced "Kur kyoo min") is the principal curcuminoid of the popular Indian spice turmeric, which is a member of the ginger family (Zingiberaceae). Turmeric's other two curcuminoids are desmethoxycurcumin and bis-desmethoxycurcumin. The curcuminoids are natural phenols that are responsible for the yellow color of turmeric. Curcumin can exist in several tautomeric forms, including a 1,3-diketo form and two equivalent enol forms. The enol form is more energetically stable in the solid phase and in solution.
Curcumin incorporates several functional groups. The aromatic ring systems, which are phenols, are connected by two α,β-unsaturated carbonyl groups. The diketones form stable enols and are readily deprotonated to form enolates; the α,β-unsaturated carbonyl group is a good Michael acceptor and undergoes nucleophilic addition. The structure was first identified in 1910 by J. Miłobędzka, Stanisław Kostanecki and Wiktor Lampe.
The biosynthetic route of curcumin has proven to be very difficult for researchers to determine. In 1973 Roughly and Whiting proposed two mechanisms for curcumin biosynthesis. The first mechanism involved a chain extension reaction by cinnamic acid and 5 malonyl-CoA molecules that eventually arylized into a curcuminoid. The second mechanism involved two cinnamate units being coupled together by malonyl-CoA. Both mechanisms use cinnamic acid as their starting point, which is derived from the amino acid phenylalanine. This is noteworthy because plant biosyntheses employing cinnamic acid as a starting point are rare compared to the more common use of p-coumaric acid. Only a few identified compounds, such as anigorufone and pinosylvin, use cinnamic acid as their start molecule. An experimentally backed route was not presented until 2008. This proposed biosynthetic route follows both the first and second mechanisms suggested by Roughley and Whiting. However, the labeling data supported the first mechanism model in which 5 malonyl-CoA molecules react with cinnamic acid to form curcumin. However, the sequencing in which the functional groups, the alcohol and the methoxy, introduce themselves onto the curcuminoid seems to support more strongly the second proposed mechanism. Therefore, it was concluded the second pathway proposed by Roughly and Whiting was correct.
Preliminary research for potential health effects 
||The neutrality of this section is disputed. (December 2011)|
|This section relies on references to primary sources. (January 2011)|
||This article may contain an excessive amount of intricate detail that may only interest a specific audience. (January 2011)|
Although some preclinical studies suggest curcumin may be useful for the prevention and treatment of several diseases, the effectiveness of curcumin has neither been confirmed in sufficient preliminary research, nor has it been demonstrated in randomized, placebo-controlled, double-blind clinical trials.
In one preliminary study, a daily dose of 2 grams of curcumin extract was found to provide pain relief that was equivalent to ibuprofen for the relief of pain associated with osteoarthritis of the knee. A survey of the literature shows a number of other potential uses and that daily doses over a 3 month period of up to 12 grams proved safe. Some commercial capsules of curcumin contain piperine, a compound found in pepper which aids absorption of curcumin into the blood stream.
The effect of curcumin on amyloid beta plaque build up, a possible major cause for Alzheimer’s, has been studied in mice. According to theory, curcumin may provide anti-inflammatory effects in a neuro-inflammatory cascade in plaque pathogenesis. The study demonstrated that both low and high doses of curcumin reduced β-amyloid plaque buildup, an effect that may be similar to that of aspirin which suppressed development of β-amyloid plaque buildup in preliminary research.
Research in the latter half of the 20th century identified curcumin as the agent responsible for most of the biological activity of turmeric. In vitro and animal studies have suggested potential biological effects associated with curcumin. At present, these effects have not been confirmed in humans.
As of 2008, clinical trials in humans were underway, studying the effect of curcumin on various diseases, including multiple myeloma, pancreatic cancer, myelodysplastic syndromes, colon cancer, psoriasis, and Alzheimer's disease.
Several preliminary research studies have identified curcumin with potential biological effects:
- In both in vitro and animal studies, curcumin has shown antitumor, antioxidant, antiarthritic, antiamyloid, anti-ischemic, and anti-inflammatory properties.
- Anti-inflammatory properties may be due to inhibition of eicosanoid biosynthesis.
- In one study, curcumin protected mice from V. vulnificus-induced septicemia.
- In rats, subcutaneously-injected curcumin improved biomarkers for hepatoprotection.
- A laboratory study found that low concentrations of curcumin interfere with Herpes simplex virus-1 (HSV-1) replication. It inhibited the recruitment of RNA polymerase II to viral DNA, thus inhibiting its transcription. This effect was independent of the effect on histone acetyltransferase activities of p300/CBP.
- One study found that curcumin may be associated with protection from infection by HSV-2 in animal models of intravaginal infections.
- A study in rats found that curcumin may act as a free radical scavenger and antioxidant, inhibiting lipid peroxidation and oxidative DNA damage, protecting against lead neurotoxicity.
- In rats, curcumin was shown to be effective in protecting against toxicity and spatial memory impairment induced by amyloid β-protein infusion.
- A study using a transgenic animal model indicated that curcumin diminished plaque burden and overall inflammation, but it also increased plaque-associated inflammatory cells suggesting enhanced clearance.
- A study found that curcumin shrank the size of plaques and reduced neurite dystrophy in an Alzheimer mouse model.
- A study found curcumin to have a synergistic effect with fish oil to protect against cognitive deficits in a transgenic rodent model.
- Preliminary studies indicate that curcumin may have a positive effect on neurogenesis in the hippocampus and may increase levels of brain-derived neurotrophic factor (BDNF) in rats.
- A curcumin pyrazole derivative was found to improve memory and was neuroprotective, stimulating BDNF in vitro and in vivo. The compound was found to be protective in animal models of brain trauma and stroke.
- In rats, curcumin may inhibit cardiac hypertrophy and affect cardiac health and repair through different mechanisms.
- In one preliminary human study, curcumin increased insulin secretion from the pancreas.
- A human study of 240 subjects observed that curcumin could reduce the risk of having a type 2 diabetes.
Preliminary cancer research 
The potential anti-cancer effects of curcumin have been the subject of several preliminary studies:
- Its potential anticancer effects may stem from an ability to induce apoptosis in cancer cells without cytotoxic effects on healthy cells. Curcumin may interfere with activity of the transcription factor NF-κB, which has been linked to a number of inflammatory diseases such as cancer.
- One study suggested curcumin may inhibit a cancer-associated complex via mechanisms yet to be defined.
- An in vitro study in a human glioblastoma cell line reported that curcumin may inhibit tumor cell proliferation, migration and invasion, and that these effects may be mediated through interference with a signaling pathway.
- When 0.2% curcumin was added to the diet of rats or mice previously given a carcinogen, it reduced incidence of colon carcinogenesis.
- In one in vitro study curcumin had phyto-estrogenic activity that might affect onset of breast cancer.
- In immunodeficient mice with breast cancer, curcumin inhibited the formation of lung metastases, possibly through the regulation of cytokines.
- A study found that curcumin might affect kidney function by reducing lipopolysaccharide-induced renal inflammation.
In Phase I clinical trials, dietary curcumin was shown to exhibit poor bioavailability (i.e., low levels in plasma and tissues). Potential factors that limit the bioavailability of curcumin include poor absorption, rapid metabolism, and rapid systemic elimination. Numerous approaches to increasing curcumin bioavailability have been explored, including the use of adjuvants like piperine.
The bioavailability of curcumin ingested in foods may be increased as a result of cooking or dissolution in oil.
Potential risks and side effects 
Kawanishi et al. remarked that curcumin, like many antioxidants, can be a "double-edged sword" where, in the test tube, carcinogenic and pro-oxidant effects may be seen in addition to anticancer and antioxidant effects. Carcinogenic effects are inferred from interference with the p53 tumor suppressor pathway, an important factor in human colon cancer. In vitro and in vivo studies suggest that curcumin can have carcinogenic effects.
Clinical studies in humans with high doses (2–12 grams) of curcumin have shown few side effects, with some subjects reporting mild nausea or diarrhea. More recently, curcumin was found to alter iron metabolism by chelating iron and suppressing the protein hepcidin, potentially causing iron deficiency in susceptible patients. Further studies seem to be necessary to establish the benefit/risk profile of curcumin.
There is no or little evidence to suggest curcumin is either safe or unsafe for pregnant women. However, there is still some concern medicinal use of products containing curcumin could stimulate the uterus, which may lead to a miscarriage, although there is not much evidence to support this claim. According to experiments done on rats and guinea pigs, there is no obvious effect (neither positive, nor negative) on the pregnancy rate or number of live or dead embryos. Curcumin has embryotoxic and teratogenic effects on zebrafishes (Danio rerio) embryos.
- "Dorland's Illustrated Medical Dictionary, 32nd Edition". Retrieved May 19, 2013. Published 2011.
- Kolev, Tsonko M.; Velcheva, Evelina A.; Stamboliyska, Bistra A.; Spiteller, Michael (2005). "DFT and experimental studies of the structure and vibrational spectra of curcumin". International Journal of Quantum Chemistry 102 (6): 1069–79. doi:10.1002/qua.20469.
- Food Standards Australia New Zealand. "Food Additives- Numerical List". Retrieved 2009-12-02.
- Miłobȩdzka, J.; v. Kostanecki, St.; Lampe, V. (1910). "Zur Kenntnis des Curcumins". Berichte der deutschen chemischen Gesellschaft 43 (2): 2163–70. doi:10.1002/cber.191004302168.
- "EPA Method 212.3: Boron (Colorimetric, Curcumin)".
- Kita, Tomoko; Imai, Shinsuke; Sawada, Hiroshi; Kumagai, Hidehiko; Seto, Haruo (2008). "The Biosynthetic Pathway of Curcuminoid in Turmeric (Curcuma longa) as Revealed by 13C-Labeled Precursors". Bioscience, Biotechnology, and Biochemistry 72 (7): 1789. doi:10.1271/bbb.80075.
- Schmitt, Bettina; Hölscher, Dirk; Schneider, Bernd (2000). "Variability of phenylpropanoid precursors in the biosynthesis of phenylphenalenones in Anigozanthos preissii". Phytochemistry 53 (3): 331–7. doi:10.1016/S0031-9422(99)00544-0. PMID 10703053.
- Gehlert, R.; Schoeppner, A.; Kindl, H. (1990). "Stilbene Synthase from Seedlings of Pinus sylvestris: Purification and Induction in Response to Fungal Infection" (pdf). Molecular Plant-Microbe Interactions 3 (6): 444–449. doi:10.1094/MPMI-3-444.
- Mancuso, C.; Barone, E. (2009). "Curcumin in clinical practice: myth or reality?". Trends in Pharmacological Science 30 (7): 333–334. doi:10.1016/j.tips.2009.04.004. PMID 19523696.
- Kuptniratsaikul, Vilai; Thanakhumtorn, Sunee; Chinswangwatanakul, Pornsiri; Wattanamongkonsil, Luksamee; Thamlikitkul, Visanu (2009). "Efficacy and Safety ofCurcuma domesticaExtracts in Patients with Knee Osteoarthritis". The Journal of Alternative and Complementary Medicine 15 (8): 891–7. doi:10.1089/acm.2008.0186. PMID 19678780. "Curcuma domestica extracts seem to be similarly efficacious and safe as ibuprofen for the treatment of knee Osteoarthritis."
- Goel, Ajay; Kunnumakkara, Ajaikumar B.; Aggarwal, Bharat B. (2008). "Curcumin as "Curecumin": From kitchen to clinic". Biochemical Pharmacology 75 (4): 787–809. doi:10.1016/j.bcp.2007.08.016. PMID 17900536. "Pilot phase I clinical trials have shown curcumin to be safe even when consumed at a daily dose of 12g for 3 months."
- Lim, GP; Chu, T; Yang, F; Beech, W (2001). "The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse". J. Neurosci. Res 21: 8370–8377. PMID 11606625.
- Aggarwal, Bharat B.; Sundaram, Chitra; Malani, Nikita; Ichikawa, Haruyo (2007). "Curcumin: the Indian solid gold". Advances In Experimental Medicine And Biology 595: 1–75. doi:10.1007/978-0-387-46401-5_1. ISBN 978-0-387-46400-8. PMID 17569205.
- Hatcher, H.; Planalp, R.; Cho, J.; Torti, F. M.; Torti, S. V. (2008). "Curcumin: From ancient medicine to current clinical trials". Cellular and Molecular Life Sciences 65 (11): 1631–52. doi:10.1007/s00018-008-7452-4. PMID 18324353.
- Ströfer, Mareike; Jelkmann, Wolfgang; Depping, Reinhard (2011). "Curcumin Decreases Survival of Hep3B Liver and MCF-7 Breast Cancer Cells". Strahlentherapie und Onkologie 187 (7): 393–400. doi:10.1007/s00066-011-2248-0. PMID 21713389.
- Aggarwal, Bharat B.; Shishodia, Shishir (2006). "Molecular targets of dietary agents for prevention and therapy of cancer". Biochemical Pharmacology 71 (10): 1397–421. doi:10.1016/j.bcp.2006.02.009. PMID 16563357.
- Choi, H.; Chun, Y.-S.; Kim, S.-W.; Kim, M.-S.; Park, J.-W. (2006). "Curcumin Inhibits Hypoxia-Inducible Factor-1 by Degrading Aryl Hydrocarbon Receptor Nuclear Translocator: A Mechanism of Tumor Growth Inhibition". Molecular Pharmacology 70 (5): 1664–71. doi:10.1124/mol.106.025817. PMID 16880289.
- Shukla, Pradeep K.; Khanna, Vinay K.; Ali, Mohd. M.; Khan, Mohd. Y.; Srimal, Rikhab C. (2008). "Anti-ischemic Effect of Curcumin in Rat Brain". Neurochemical Research 33 (6): 1036–43. doi:10.1007/s11064-007-9547-y. PMID 18204970.
- Stix, G. (February 2007). "Spice Healer". Scientific American 296 (2): 66. doi:10.1038/scientificamerican0207-66.
- Srivastava, K.C.; Bordia, A.; Verma, S.K. (1995). "Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets". Prostaglandins, Leukotrienes and Essential Fatty Acids 52 (4): 223. doi:10.1016/0952-3278(95)90040-3.
- Na, HS; Cha, MH; Oh, DR; Cho, CW, et al. (2011). "Protective mechanism of curcumin against Vibrio vulnificus infection". FEMS immunology and medical microbiology 63 (3): 355–62. doi:10.1111/j.1574-695X.2011.00855.x. PMID 22092562.
- Ghosh, N.; Ghosh, R.; Mandal, V.; Mandal, S. C. (2011). "Recent advances in herbal medicine for treatment of liver diseases". Pharmaceutical Biology 49 (9): 970–988. doi:10.3109/13880209.2011.558515. PMID 21595500.
- Barreto, R; Kawakita, S; Tsuchiya, J; Minelli, E, et al. (2005). "Hepatoprotective effect of a curcumin/absinthium compound in experimental severe liver injury". Chinese Journal of Digestive Diseases 6 (1): 31. doi:10.1111/j.1443-9573.2005.00184.x.
- Kutluay, Sebla B.; Doroghazi, James; Roemer, Martha E.; Triezenberg, Steven J. (2008). "Curcumin inhibits herpes simplex virus immediate-early gene expression by a mechanism independent of p300/CBP histone acetyltransferase activity". Virology 373 (2): 239–47. doi:10.1016/j.virol.2007.11.028. PMC 2668156. PMID 18191976.
- Bourne, Krystyn Z.; Bourne, Nigel; Reising, Shirley F.; Stanberry, Lawrence R. (1999). "Plant products as topical microbicide candidates: Assessment of in vitro and in vivo activity against herpes simplex virus type 2". Antiviral Research 42 (3): 219–26. doi:10.1016/S0166-3542(99)00020-0. PMID 10443534.
- Shukla, Pradeep K; Khanna, Vinay K; Khan, Mohd Y; Srimal, Rikhab C (2003). "Protective effect of curcumin against lead neurotoxicity in rat". Human & Experimental Toxicology 22 (12): 653. doi:10.1191/0960327103ht411oa.
- Frautschy, S; Hu, W; Kim, P; Miller, SA, et al. (2001). "Phenolic anti-inflammatory antioxidant reversal of AÎ²-induced cognitive deficits and neuropathology". Neurobiology of Aging 22 (6): 993–1005. doi:10.1016/S0197-4580(01)00300-1. PMID 11755008.
- Chu, Giselle P.; Chu, Teresa; Yang, Fusheng; Beech, Walter, et al. (2001). "The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse". The Journal of Neuroscience 21 (21): 8370–7. PMID 11606625.
- Garcia-Alloza, M.; Borrelli, L. A.; Rozkalne, A.; Hyman, B. T.; Bacskai, B. J. (2007). "Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model". Journal of Neurochemistry 102 (4): 1095–104. doi:10.1111/j.1471-4159.2007.04613.x. PMID 17472706.
- Ma, Q.-L.; Yang, F.; Rosario, E. R.; Ubeda, O. J., et al. (2009). " -Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin". Journal of Neuroscience 29 (28): 9078–89. doi:10.1523/JNEUROSCI.1071-09.2009. PMID 19605645.
- Xu, Ying; Ku, Baoshan; Cui, Li; Li, Xuejun; Barish, Philip A., et al. (2007). "Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats". Brain Research 1162: 9–18. doi:10.1016/j.brainres.2007.05.071. PMID 17617388.
- Wu, Aiguo; Ying, Zhe; Gomez-Pinilla, Fernando (2006). "Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition". Experimental Neurology 197 (2): 309–17. doi:10.1016/j.expneurol.2005.09.004. PMID 16364299.
- Bala, Kiran; Tripathy, B. C.; Sharma, Deepak (2006). "Neuroprotective and Anti-ageing Effects of Curcumin in Aged Rat Brain Regions". Biogerontology 7 (2): 81–9. doi:10.1007/s10522-006-6495-x. PMID 16802111.
- Maher, Pamela; Akaishi, Tatsuhiro; Schubert, David; Abe, Kazuho (2010). "A pyrazole derivative of curcumin enhances memory". Neurobiology of Aging 31 (4): 706–9. doi:10.1016/j.neurobiolaging.2008.05.020. PMID 18639368.
- Liu, Y.; Dargusch, R.; Maher, P.; Schubert, D. (2008). "A broadly neuroprotective derivative of curcumin". Journal of Neurochemistry 105 (4): 1336–1345. doi:10.1111/j.1471-4159.2008.05236.x. PMID 18208543.
- Wu, A.; Ying, Z.; Schubert, D.; Gomez-Pinilla, F. (2011). "Brain and spinal cord interaction: a dietary curcumin derivative counteracts locomotor and cognitive deficits after brain trauma". Neurorehabilitation and Neural Repair 25 (4): 332–342. doi:10.1177/1545968310397706. PMC 3258099. PMID 21343524.
- Lapchak, P.; Schubert, D. R.; Maher, P. A. (2011). "Delayed Treatment with a Novel Neurotrophic Compound Reduces Behavioral Deficits in Rabbit Ischemic Stroke". Journal of Neurochemistry 116 (1): 122–131. doi:10.1111/j.1471-4159.2010.07090.x. PMC 3004475. PMID 21054387.
- Nirmala, C.; Puvanakrishnan, R. (1996). "Protective role of curcumin against isoproterenol induced myocardial infarction in rats". Molecular and Cellular Biochemistry 159 (2): 85–93.
- Ghosh, S.; Salloum, F.; Abbate, A.; Krieg, R.; Sica, D., et al. (2010). "Curcumin prevents cardiac remodeling secondary to chronic renal failure through deactivation of hypertrophic signaling in rats". Am J Physiol Heart Circ Physiol. 299 (4): 975–984. doi:10.1152/ajpheart.00154.2010.
- Wang, N-P.; Wang, Z-F.; Tootle, S.; Philip, T.; Zhao, Z-Q. (2012). "Curcumin promotes cardiac repair and ameliorates cardiac dysfunction following myocardial infarction". British Journal of Pharmacology 167 (7): 1550–1562. doi:10.1111/j.1476-5381.2012.02109.x.
- Wickenberg, J.; Ingemansson, S.; Hlebowicz, J. (2010). "Effects of Curcuma longa (turmeric) on postprandial plasma glucose and insulin in healthy subjects". Nutrition Journal 9 (43). doi:10.1186/1475-2891-9-43.
- Chuengsamarn S.; Rattanamongkolgul S.; Luechapudiporn R.; Phisalaphong C.; Jirawatnotai S. (2012). "Curcumin Extract for Prevention of Type 2 Diabetes". Diabetes Care 35 (11). doi:10.2337/dc12-0116. PMID 22773702.
- Aggarwal, B. B.; Shishodia, S. (2004). "Suppression of the Nuclear Factor-κB Activation Pathway by Spice-Derived Phytochemicals: Reasoning for Seasoning". Annals of the New York Academy of Sciences 1030: 434–441. doi:10.1196/annals.1329.054. PMID 15659827.
- Beevers, C. S.; Chen, L.; Liu, L.; Luo, Y.; et al. (2009). "Curcumin disrupts the Mammalian target of rapamycin-raptor complex". Cancer Research 69 (3): 1000–1008. doi:10.1158/0008-5472.CAN-08-2367. PMID 19176385.
- Ravindran, J.; Prasad, S.; Aggarwal, B. B. (2009). "Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively?". The AAPS Journal 11 (3): 495–510. doi:10.1208/s12248-009-9128-x. PMC 2758121. PMID 19590964.
- Senft, C.; Polacin, M.; Priester, M.; Seifert, V.; Kögel, D.; Weissenberger, J. (2010). "The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas". BMC Cancer 10: 491. doi:10.1186/1471-2407-10-491. PMC 2949804. PMID 20840775.
- Data from sixteen scientific articles reported in the Chemoprevention Database
- Bachmeier, B. E.; Mirisola, V.; Romeo, F.; Generoso, L.; Esposito, A.; Dell’Eva, R.; et al. (2010). "Reference profile correlation reveals estrogen-like trancriptional activity of Curcumin". Cell Physiology and Biochemistry 26 (3): 471–482. doi:10.1159/000320570. PMID 20798532.
- Bachmeier, B. E.; Nerlich, A.; Iancu, C.; Cilli, M., et al. (2007). "The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice" (pdf). Cell Physiology and Biochemistry 19 (1–4): 137–152. doi:10.1159/000099202. PMID 17310108.
- Bachmeier, B. E.; Mohrenz, I. V.; Mirisola, V.; Schleicher, E., et al. (2008). "Curcumin downregulates the inflammatory cytokines CXCL1 and −2 in breast cancer cells via NFκB". Carcinogenesis 29 (4): 779–789. doi:10.1093/carcin/bgm248. PMID 17999991.
- Kilian, P. H.; Kronski, E.; Michalik, K.M.; Barbieri, O., et al. (2012). "Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and −2". Carcinogenesis 33 (12): 2507–19. doi:10.1093/carcin/bgs312. PMID 23042094.
- Zhong, F.; Chen, H.; Han, L.; Jin, Y.; Wang, W. (2011). "Curcumin attenuates lipopolysaccharide-induced renal inflammation". Biological and Pharmaceutical Bulletin 34 (2): 226–232. doi:10.1248/bpb.34.226. PMID 21415532.
- Anand, P.; Kunnumakkara, A. B.; Newman, R. A.; Aggarwal, B. B. (2007). "Bioavailability of curcumin: problems and promises". Molecular Pharmaceutics 4 (6): 807–818. doi:10.1021/mp700113r. PMID 17999464.
- Marczylo, T. H.; Verschoyle, R. D.; Cooke, D. N.; Morazzoni, P.; Steward, W. P.; Gescher, A. J. (2007). "Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine". Cancer Chemotherapy and Pharmacology 60 (2): 171–177. doi:10.1007/s00280-006-0355-x. PMID 17051370.
- Bachmeier BE, Iancu CM, Killian PH, Kronski E, Mirisola V, Angelini G, et al. (2009). "Overexpression of the ATP binding cassette gene ABCA1 determines resistance to Curcumin in M14 melanoma cells". Mol Cancer 8: 129–141. doi:10.1186/1476-4598-8-129. PMC 2804606. PMID 20030852.
- Kawanishi, S.; Oikawa, S.; Murata, M. (2005). "Evaluation for safety of antioxidant chemopreventive agents". Antioxidants & Redox Signaling 7 (11–12): 1728–1739. doi:10.1089/ars.2005.7.1728. PMID 16356133.
- Moos, P. J.; Edes, K.; Mullally, J. E.; Fitzpatrick, F. A. (2004). "Curcumin impairs tumor suppressor p53 function in colon cancer cells". Carcinogenesis 25 (9): 1611–1617. doi:10.1093/carcin/bgh163. PMID 15090465.
- Burgos-Moron, E.; Calderón-Montaño, J. M.; Salvador, J.; Robles, A.; López-Lázaro, M. (2010). "The dark side of curcumin" (pdf). International Journal of Cancer 126 (7): 1771–1775. doi:10.1002/ijc.24967. PMID 19830693.
- Dance-Barnes, S. T.; Kock, N. D.; Moore, J. E.; Lin, E. Y.; Mosley, L. J., et al. (2009). "Lung tumor promotion by curcumin". Carcinogenesis 30 (6): 1016–1023. doi:10.1093/carcin/bgp082. PMC 2691137. PMID 19359593.
- López-Lázaro, M.; Kock, N. D.; Moore, J. E.; Lin, E. Y.; Mosley, L. J., et al. (2008). "Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent". Molecular Nutrition and Food Research 52 (Supplement 1): S103–S127. doi:10.1002/mnfr.200700238. PMID 18496811.
- Hsu, C. H.; Cheng, A. L. (2007). "Clinical studies with curcumin". Advances in Experimental Medicine and Biology. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 595: 471–480. doi:10.1007/978-0-387-46401-5_21. ISBN 978-0-387-46400-8. PMID 17569225.
- Jiao, Y.; Wilkinson, J.; Di, X.; Wang, W.; Hatcher, H., et al. (January 2009). "Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator". Blood 113 (2): 462–469. doi:10.1182/blood-2008-05-155952. PMC 2615657. PMID 18815282.
- Vijayalaxmi (1980). "Genetic effects of turmeric and curcumin in mice and rats". Mutation Research 79 (2): 125–132. doi:10.1016/0165-1218(80)90080-4. PMID 7432370.
- Wu, J. Y.; Lin, C. Y.; Lin, T. W.; Ken, C. F.; Wen, Y. D. (2007). "Curcumin Affects Development of Zebrafish Embryo". Biol. Pharm. Bull 30 (7): 1336–1339. doi:10.1248/bpb.30.1336. PMID 17603177.
See also: Esatbeyoglu, Tuba; Huebbe, Patricia; Ernst, Insa M. A.; Chin, Dawn, et al. (2012). "Curcumin-From Molecule to Biological Function". Angewandte Chemie International Edition 51 (22): 5308. doi:10.1002/anie.201107724.
- Turmeric and curcumin, from Memorial Sloan-Kettering Cancer Center
- Turmeric and curcumin, from M.D. Anderson Cancer Center
- Turmeric, from the University of Maryland Medical Center